Verastem Inc. Reports Increased Operating Expenses and Net Loss

TipRanksNov 21 22:54 ET

Byondis Appoints Louis Denis, M.D., as Chief Medical Officer

BusinesswireNov 19 01:11 ET

RBC Capital Maintains Verastem(VSTM.US) With Buy Rating, Maintains Target Price $13

Moomoo NewsNov 7 07:31 ET · Ratings

A. G. P. Maintains Verastem(VSTM.US) With Buy Rating, Cuts Target Price to $14

Moomoo NewsNov 7 07:31 ET · Ratings

Verastem Price Target Lowered to $14 From $20 at Alliance Global Partners

TipRanksNov 7 07:06 ET

Express News | Corrected-Verastem Inc: Qtrly Adj Shr Loss $0.88 (Not '$0.71')

ReutersNov 6 17:09 ET